To direct the President to establish an interagency task force to review, and provide recommendations on, the impact of addictive design features on youth mental health, to direct the Secretary of Health and Human Services to establish grant programs to support the activities of the task force, and for other purposes.
Summary
HR9948 is an early-stage bill that establishes an interagency task force to study addictive design features and youth mental health, with grant programs to support the task force. No funding amount is specified, and the bill has no direct regulatory or financial impact on any public company. It is in the earliest legislative stage with limited momentum.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9948 is in the earliest legislative stage with no funding or direct regulatory impact.
- 2.No public companies are directly affected; the bill only establishes a study and grant programs.
- 3.Investors should monitor for committee action or amendments that could introduce specific funding or regulatory teeth.
Market Implications
No market implications at this stage. The bill does not affect any sector's revenue, costs, or regulatory environment. Investors should ignore until substantive committee action or funding details emerge.
Full Analysis
HR9948, introduced on July 27, 2026, by Rep. Balint (D-VT) and three cosponsors, directs the President to create an interagency task force to review the impact of addictive design features on youth mental health and to provide recommendations. It also directs the Secretary of Health and Human Services to establish grant programs to support the task force's activities. The bill has been referred to the House Committees on Energy and Commerce and Education and Workforce. No specific funding amount is authorized; the bill is purely procedural at this stage. The legislative path is long: it must pass through committee markup, House floor vote, Senate consideration, and potential presidential action. Given the early stage, no direct market impact exists. The bill does not mandate any changes to company practices, impose penalties, or allocate funds to any specific sector. The presidential action on chemical manufacturing regulatory relief is unrelated and ignored. Without a concrete funding mechanism or regulatory mandate, no tickers meet the confidence gate for inclusion.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND): $1.8B Department of State Federal Award
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Securing America’s Defense Supply Chains and Ensuring Domestic Acquisition of Critical Materials
This executive order restricts waivers for foreign-sourced critical materials in defense contracts, effective January 1, 2027, and mandates that defense contractors map their supply chains from raw materials to end products, vet subcontractors for risks, and prohibit covered materials from unreliable foreign suppliers. It directs the Secretary of War to enforce strict compliance, including requiring mitigation plans for any non-compliant materials and establishing penalties for fraud or willful noncompliance.
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →